Wikipedia -WSS

Wikipedia

author：focus 2025-10-01 00:05:34 - browse：1

The Food and Drug Administration on Friday approved a new, rapid-acting medicine made by Sage Therapeutics to treat postpartum depression, the first oral treatment for the condition. But the agency denied the company’s application for an indication for major depression, a much larger potential market.

The drug, which will be sold under the brand name Zurzuvae, is not meant to be taken chronically. Patients take it orally for 14 days. In two clinical trials, the drug was found to significantly improve depressive symptoms more than a placebo. The effect was maintained for four weeks after treatment.

“Maternal mental health has been sidelined for far too long, but today’s approval of Zurzuvae helps to change that. Women have been waiting for an oral medicine that can specifically and rapidly improve the symptoms of PPD and we are proud to be able to deliver that,” said Barry Greene, Sage’s CEO, in a press release.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

leisure time

WSS

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Telehealth startups are trying to fill the menopause care vacuum

Secretariat’s lessons for human medicine

MD Anderson's Padmanee Sharma responds to research credit suit

Medicare Advantage enrollment hits roughly 33.4 million

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

explore

Wikipedia

hotspot

Supreme Court strikes down use of affirmative action

Reporting on presidential health from Reagan to Trump and Biden

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Dementia risk linked to living in disadvantaged areas: Study

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Trump demands the U.S. pay no more for drugs than other countries … again

Extensive review finds private equity owners jack up cost of care

At least 13 dead in Texas as scorching temps continue

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

explore

Flagship Pioneering startup Sonata Therapeutics lays off 21

Measles policy set amid Florida outbreak alarms vaccine proponents

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Obamacare plans could cover weight loss drugs

Surprise medical billing ban raises prices elsewhere

Stanford president’s abrupt resignation sparks debate

leisure time

entertainment

hotspot

explore